{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-023676","form_type":"8-K","ticker":"NRC","cik":"0000070487","company_name":"NRC HEALTH","filed_at":"2025-07-28T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.181228+00:00","generated_at":"2026-05-18T00:37:21.980229+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"NRC Health Q2 2025: TRCV grows 2% sequentially; net margin 0% on exec comp; adj EBITDA margin 30%","bullets":["TRCV grew 2% sequentially, third consecutive quarter of growth and highest since Q1 2021.","Net margin 0% due to non-recurring executive compensation; adjusted EBITDA margin 30%.","Declared $0.12 quarterly dividend; payable Oct 10, 2025 to holders of record Sept 26, 2025.","Repurchased 381,736 shares at $14.96 avg in Q2; $16.1M returned to shareholders YTD.","New CEO Trent Green reinstated quarterly earnings call; cites strong customer feedback."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-023676","json":"https://secwatch.observer/filing/0001437749-25-023676.json","markdown":"https://secwatch.observer/filing/0001437749-25-023676.md","text":"https://secwatch.observer/filing/0001437749-25-023676.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/70487/000143774925023676/0001437749-25-023676-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/70487/000143774925023676/nrc20250725_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T00:37:21.980229+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}